Clinical trial
Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on…
NCT00231725 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00231725 |
|---|---|
| Title | Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin |
| Official title | Complaints Associated With Use of Pre-Filled Pen B When Used by Patients With Type 2 Diabetes on Twice-Daily Insulin Therapy |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | insulin lispro injection [rDNA origin] Low Mix |
| Enrollment | 370 |
| Start date | Sep 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Oct 4, 2005 |
| Last update posted | Jun 27, 2007 |
| Countries | Spain, United Kingdom, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: